CIA
MEDP icon

CSat Investment Advisory’s Medpace MEDP Stock Holding History

CSat Investment Advisory’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-170
Closed -$19K – 776
2020
Q3 		$19K Buy
170
+20
+13% +$2.31K ﹤0.01% 877
2020
Q2 		$14K Buy
+150
New +$12.8K ﹤0.01% 948

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

CSat Investment Advisory's MEDP Position: Q4 2020 in Review

CSat Investment Advisory sold out of Medpace (MEDP) in Q4 2020, closing a stake of 170 shares — an estimated $19K sold.

CSat Investment Advisory first reported a position in MEDP in Q2 2020 and held it in 2 quarters. The position peaked at $19K in Q3 2020. 316 funds tracked by Wall St. Rank hold MEDP as of Q4 2020.

  • CSat Investment Advisory reported no remaining Medpace position as of Q4 2020 after selling out during the quarter.
  • CSat Investment Advisory sold 170 Medpace shares in Q4 2020, an estimated $19K.
  • CSat Investment Advisory first reported a position in Medpace in Q2 2020 and held it in 2 quarters.
  • CSat Investment Advisory's Medpace position peaked at $19K in Q3 2020.
  • 316 funds tracked by Wall St. Rank held Medpace as of Q4 2020.

Based on CSat Investment Advisory's 13F filing for Q4 2020, filed 12 Feb 2021.